Ozempic and similar drugs linked to gastrointestinal conditions, Canadian researchers find

Researchers examined a random sample of health insurance claim records of 16 million patients in the U.S. between 2006 and 2020 for use of semaglutide drugs

Related Keywords

Canada ,United States ,United Kingdom ,British ,American ,Canadian ,Kate Hanna ,Joe Oconnal ,Mohit Sodhi ,Mahyar Etminan ,Health Canada ,Journal Of The American Medical Association ,University Of British Columbia ,Novo Nordisk ,Drug Administration ,Log Increate Free ,British Columbia ,American Medical Association ,Risk ,Study ,Diabetes ,Ozempic ,People ,Obesity ,Nausea ,Gastroparesis ,Canadian Press ,